ECSP14010605A - Sistema para la administración de fármacos - Google Patents
Sistema para la administración de fármacosInfo
- Publication number
- ECSP14010605A ECSP14010605A ECIEPI201410605A ECPI201410605A ECSP14010605A EC SP14010605 A ECSP14010605 A EC SP14010605A EC IEPI201410605 A ECIEPI201410605 A EC IEPI201410605A EC PI201410605 A ECPI201410605 A EC PI201410605A EC SP14010605 A ECSP14010605 A EC SP14010605A
- Authority
- EC
- Ecuador
- Prior art keywords
- core
- membrane
- intermediate layer
- delivery system
- therapeutically active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
Abstract
Un sistema para la administración de fármacos para la liberación controlada de sustancias terapéuticamente activas a una tasa de liberación predeterminada, esencialmente constante durante un período de tiempo prolongado. El sistema de administración comprende al menos un núcleo que comprende dicha(s) sustancia(s) terapéuticamente activa(s), al menos una membrana que encierra el núcleo y una capa intermedia de un material sustancialmente inerte, en donde la capa intermedia se aplica entre el núcleo y la membrana o entre las dos capas de membrana.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20125069 | 2012-01-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP14010605A true ECSP14010605A (es) | 2015-12-31 |
Family
ID=47666152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECIEPI201410605A ECSP14010605A (es) | 2012-01-23 | 2014-07-23 | Sistema para la administración de fármacos |
Country Status (39)
Country | Link |
---|---|
US (1) | US10500381B2 (es) |
EP (1) | EP2806893B1 (es) |
JP (1) | JP6236401B2 (es) |
KR (1) | KR102004014B1 (es) |
CN (1) | CN104144702B (es) |
AR (1) | AR089765A1 (es) |
AU (1) | AU2013213514B2 (es) |
BR (1) | BR112014017834B1 (es) |
CA (1) | CA2861947A1 (es) |
CL (1) | CL2014001935A1 (es) |
CO (1) | CO7020911A2 (es) |
CR (1) | CR20140358A (es) |
CU (1) | CU24431B1 (es) |
CY (1) | CY1120773T1 (es) |
DK (1) | DK2806893T3 (es) |
DO (1) | DOP2014000171A (es) |
EA (1) | EA032208B1 (es) |
EC (1) | ECSP14010605A (es) |
ES (1) | ES2691635T3 (es) |
HK (1) | HK1203802A1 (es) |
HR (1) | HRP20181707T1 (es) |
IL (1) | IL233599B (es) |
LT (1) | LT2806893T (es) |
MX (1) | MX355961B (es) |
MY (1) | MY172812A (es) |
NZ (1) | NZ627461A (es) |
PE (1) | PE20141818A1 (es) |
PH (1) | PH12014501654B1 (es) |
PL (1) | PL2806893T3 (es) |
PT (1) | PT2806893T (es) |
RS (1) | RS57911B1 (es) |
SG (1) | SG11201404032SA (es) |
SI (1) | SI2806893T1 (es) |
TR (1) | TR201815247T4 (es) |
TW (1) | TWI626951B (es) |
UA (1) | UA116197C2 (es) |
UY (1) | UY34583A (es) |
WO (1) | WO2013110856A1 (es) |
ZA (1) | ZA201406206B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102237799B1 (ko) | 2012-11-14 | 2021-04-08 | 더블유.알. 그레이스 앤드 캄파니-콘. | 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물 |
ES2699003T3 (es) * | 2014-06-28 | 2019-02-06 | Laboratorios Andromaco S A | Pesario de cerclaje que contiene progesterona de liberación prolongada, sostenida y continua, usado para la prevención de partos prematuros |
KR20180093255A (ko) * | 2015-12-21 | 2018-08-21 | 바이엘 오와이 | 질용 고리의 제조 방법 |
WO2018202574A1 (en) | 2017-05-04 | 2018-11-08 | Bayer Oy | Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception |
WO2019063382A1 (en) | 2017-09-27 | 2019-04-04 | Bayer Oy | METHOD FOR MODIFYING THE RELEASE OF A THERAPEUTICALLY ACTIVE AGENT FROM AN ELASTOMERIC MATRIX |
CN109954198B (zh) * | 2017-12-25 | 2021-10-12 | 先健科技(深圳)有限公司 | 药物球囊及其制备方法 |
JP2022520667A (ja) * | 2019-02-19 | 2022-03-31 | パーティクル サイエンシーズ, インコーポレイテッド | 隔室化された薬物送達デバイス |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19975054I2 (de) * | 1987-08-08 | 2000-04-13 | Akzo Nobel Nv | Kontrazeptives Implantat |
US5660848A (en) * | 1994-11-02 | 1997-08-26 | The Population Council, Center For Biomedical Research | Subdermally implantable device |
US5916595A (en) * | 1997-12-12 | 1999-06-29 | Andrx Pharmaceutials, Inc. | HMG co-reductase inhibitor |
NZ330726A (en) * | 1998-06-18 | 2000-10-27 | Dec Res | Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate |
AU2001258442A1 (en) | 2000-05-10 | 2001-11-20 | Leiras Oy | Drug delivery device, especially for the delivery of levonorgestrel |
WO2002032433A1 (en) * | 2000-10-20 | 2002-04-25 | Leiras Oy | Drug delivery system |
US20040247674A1 (en) | 2001-08-31 | 2004-12-09 | Timo Haapakumpu | Drug delivery system |
DE10209979A1 (de) | 2002-03-07 | 2003-09-25 | Ratiopharm Gmbh | Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung |
US20050013863A1 (en) * | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
PL1740154T3 (pl) | 2004-03-12 | 2009-11-30 | Biodel Inc | Kompozycje insuliny o ulepszonym wchłanianiu |
DK1629844T4 (da) | 2004-07-13 | 2012-05-29 | Bayer Schering Pharma Oy | Retarderet indgivelsessystem med kontrolleret initialudbrud |
US20060024362A1 (en) * | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
US20090208575A1 (en) * | 2005-01-03 | 2009-08-20 | Lupin Limited | Pharmaceutical Composition Of Acid Labile Substances |
US9198871B2 (en) * | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US20060165776A1 (en) * | 2005-08-31 | 2006-07-27 | Ramesh Sesha | Antidepressant oral pharmaceutical compositions |
US8137327B2 (en) | 2006-06-16 | 2012-03-20 | Family Health International | Vaginal drug delivery system and method |
JP2010509964A (ja) * | 2006-11-20 | 2010-04-02 | ナームローゼ・フエンノートチヤツプ・オルガノン | らせん形薬物送達システム |
US8741329B2 (en) * | 2007-09-21 | 2014-06-03 | Merck Sharp & Dohme B.V. | Drug delivery system |
TW200927141A (en) | 2007-11-22 | 2009-07-01 | Bayer Schering Pharma Oy | Vaginal delivery system |
EP2140860A1 (en) | 2008-07-03 | 2010-01-06 | Bayer Schering Pharma Oy | An improved method of contraception |
FI121000B (fi) | 2008-11-19 | 2010-06-15 | Bayer Schering Pharma Oy | Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi |
CN103347496A (zh) * | 2010-12-27 | 2013-10-09 | 道康宁公司 | 药物递送分散体以及由其形成的膜 |
-
2013
- 2013-01-21 AR ARP130100173A patent/AR089765A1/es unknown
- 2013-01-22 CU CU2014000094A patent/CU24431B1/es unknown
- 2013-01-22 PL PL13702817T patent/PL2806893T3/pl unknown
- 2013-01-22 UY UY0001034583A patent/UY34583A/es not_active Application Discontinuation
- 2013-01-22 KR KR1020147023356A patent/KR102004014B1/ko active IP Right Grant
- 2013-01-22 CA CA2861947A patent/CA2861947A1/en not_active Abandoned
- 2013-01-22 RS RS20181218A patent/RS57911B1/sr unknown
- 2013-01-22 DK DK13702817.1T patent/DK2806893T3/en active
- 2013-01-22 AU AU2013213514A patent/AU2013213514B2/en not_active Ceased
- 2013-01-22 TW TW102102306A patent/TWI626951B/zh not_active IP Right Cessation
- 2013-01-22 LT LTEP13702817.1T patent/LT2806893T/lt unknown
- 2013-01-22 MY MYPI2014701990A patent/MY172812A/en unknown
- 2013-01-22 ES ES13702817.1T patent/ES2691635T3/es active Active
- 2013-01-22 MX MX2014008906A patent/MX355961B/es active IP Right Grant
- 2013-01-22 WO PCT/FI2013/050068 patent/WO2013110856A1/en active Application Filing
- 2013-01-22 CL CL2014001935A patent/CL2014001935A1/es unknown
- 2013-01-22 UA UAA201409275A patent/UA116197C2/uk unknown
- 2013-01-22 SG SG11201404032SA patent/SG11201404032SA/en unknown
- 2013-01-22 NZ NZ627461A patent/NZ627461A/en not_active IP Right Cessation
- 2013-01-22 PT PT13702817T patent/PT2806893T/pt unknown
- 2013-01-22 JP JP2014552669A patent/JP6236401B2/ja active Active
- 2013-01-22 TR TR2018/15247T patent/TR201815247T4/tr unknown
- 2013-01-22 CN CN201380006458.1A patent/CN104144702B/zh active Active
- 2013-01-22 EA EA201400834A patent/EA032208B1/ru not_active IP Right Cessation
- 2013-01-22 PE PE2014001141A patent/PE20141818A1/es active IP Right Grant
- 2013-01-22 BR BR112014017834-8A patent/BR112014017834B1/pt not_active IP Right Cessation
- 2013-01-22 SI SI201331216T patent/SI2806893T1/sl unknown
- 2013-01-22 EP EP13702817.1A patent/EP2806893B1/en active Active
- 2013-01-22 US US14/371,848 patent/US10500381B2/en not_active Expired - Fee Related
-
2014
- 2014-07-10 IL IL233599A patent/IL233599B/en active IP Right Grant
- 2014-07-18 PH PH12014501654A patent/PH12014501654B1/en unknown
- 2014-07-23 DO DO2014000171A patent/DOP2014000171A/es unknown
- 2014-07-23 CO CO14160132A patent/CO7020911A2/es unknown
- 2014-07-23 CR CR20140358A patent/CR20140358A/es unknown
- 2014-07-23 EC ECIEPI201410605A patent/ECSP14010605A/es unknown
- 2014-08-22 ZA ZA2014/06206A patent/ZA201406206B/en unknown
-
2015
- 2015-05-05 HK HK15104265.3A patent/HK1203802A1/xx not_active IP Right Cessation
-
2018
- 2018-10-17 HR HRP20181707TT patent/HRP20181707T1/hr unknown
- 2018-10-18 CY CY181101075T patent/CY1120773T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP14010605A (es) | Sistema para la administración de fármacos | |
LTPA2019508I1 (lt) | Vaistų pristatymo sistema, skirta sunkiai vandenyje tirpstančių, farmaciškai aktyvių medžiagų, pateikimui | |
SV2015005115A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
WO2014116650A3 (en) | Transdermal drug delivery system and method | |
CY1116638T1 (el) | Διαδερμικο θεραπευτικο συστημα για την χορηγηση μιας δραστικης ουσιας | |
EP2589379A4 (en) | TRANSDERMAL AGGREGATE FREEZING SYSTEM WITH DONEPEZIL | |
SG194155A1 (en) | Multilayer thin film drug delivery device and methods of making and using the same | |
CL2009001556A1 (es) | Sistema de administración transdermica de fármacos que comprende una capa que contiene fármaco que comprende una matriz polimérica que contiene estradiol como unico fármaco; método de elaboración; útil para administrar estradiol. | |
MX354444B (es) | Dispositivos implantables heterogeneos para suministro de medicamento. | |
DK2613784T3 (da) | Indretning til transdermal indgivelse af lægemiddel | |
CO2019000643A2 (es) | Formulaciones gastrorretentivas orales y usos de las mismas | |
MX2016008138A (es) | Sistema para el suministro transdermico de ingredientes activos. | |
CL2013000477A1 (es) | Formulacion farmaceutica oral de liberacion inmediata que comprende nalbufina o una sal de la misma, y al menos, un soporte de granulacion hidrofilo, un aglutinante hidrofilo y un lubricante, util para el tratamiento del dolor y la dependencia a los opioides. | |
BR112013029199A2 (pt) | sistema de distribuição de fármacos, dispositivo de distribuição de dois fármacos, método para preparar o mesmo, comprimido para administração sublingual de um ingrediente ativo, e, método para a administração de um ingrediente ativo a um indivíduo | |
EA201400737A1 (ru) | Система доставки на основе множества пеллет с немедленным высвобождением активного вещества | |
ES2570205T3 (es) | Sistema terapéutico transdérmico con pequeña tendencia a la cristalización espontánea | |
MY166972A (en) | Transdermal delivery system containing galantamine or salts thereof | |
CR20150363A (es) | Combinación de un medicamento que comprende fenilefrina y paracetamol | |
TH95747B (th) | การนำส่งทางผิวหนังของเมปตาซินอล | |
TH95747A (th) | การนำส่งทางผิวหนังของเมปตาซินอล | |
TH164080B (th) | รูปเเบบยาของเเข็ง | |
AR090022A1 (es) | Sistema de administracion de medicamentos por tubo de alginato y metodo a ese efecto | |
UA113061C2 (xx) | Система доставки лікарського засобу | |
EA201992463A1 (ru) | Система доставки лекарственного средства | |
ES2328653B1 (es) | Combinacion de sustancias activas para el tratamiento de la diabetes. |